These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 985031

  • 21. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A, Vacca U, Pirro R, Cerone G.
    Clin Ter; 1975 Aug 15; 74(3):265-70. PubMed ID: 1227747
    [No Abstract] [Full Text] [Related]

  • 22. Reinstatement of vaginal cycles in aged female rats.
    Linnoila M, Cooper RL.
    J Pharmacol Exp Ther; 1976 Nov 15; 199(2):477-82. PubMed ID: 988180
    [Abstract] [Full Text] [Related]

  • 23. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
    Cavagnini F, Pontiroli AE, Raggi U, Peracchi M, Malinverni A.
    Folia Endocrinol; 1973 Dec 15; 26(6):483-9. PubMed ID: 4801258
    [No Abstract] [Full Text] [Related]

  • 24. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M, Jurcovicová J, Németh S, Vigas M.
    Endocrinol Exp; 1988 Dec 15; 22(4):243-8. PubMed ID: 3243205
    [Abstract] [Full Text] [Related]

  • 25. Delayed L-DOPA-induced hyperalgesia.
    Shimizu T, Iwata S, Miyata A, Fukuda T, Nomoto M.
    Pharmacol Biochem Behav; 2006 Nov 15; 85(3):643-7. PubMed ID: 17141847
    [Abstract] [Full Text] [Related]

  • 26. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
    Nowicki S, Levin G, Enero MA.
    J Pharmacol Exp Ther; 1993 Mar 15; 264(3):1377-80. PubMed ID: 8450472
    [Abstract] [Full Text] [Related]

  • 27. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO, Stoa RF, Thorsen T, Aarskog D.
    Acta Paediatr Scand; 1977 Jan 15; 66(1):81-4. PubMed ID: 831384
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Effect of L-dopa combined with benserazide on hemodynamics and motor activity in hypoxic rats].
    Boismare F, Le Poncin M, Belliard JP, Hacpille L.
    C R Seances Soc Biol Fil; 1975 Jan 15; 169(1):203-8. PubMed ID: 126730
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitor.
    Doller HJ, Connor JD, Lock DR, Sloviter RS, Dvorchik BH, Vesell ES.
    Drug Metab Dispos; 1978 Jan 15; 6(2):164-8. PubMed ID: 26532
    [Abstract] [Full Text] [Related]

  • 37. L-Dopa inhibits prolactin secretion in proestrous rats.
    Wiggins JF, Fernstrom JD.
    Endocrinology; 1977 Aug 15; 101(2):469-74. PubMed ID: 560295
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Possible mechanism of adverse reaction following levodopa plus benserazide treatment.
    Messiha FS.
    Br J Pharmacol; 1977 May 15; 60(1):55-7. PubMed ID: 884390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.